NEJM: 孢子丝菌病样皮肤案例报道

2015-10-29 chenshuo 译 MedSci原创

男性,25岁,以往有患过克罗恩病病史,以英夫利昔单抗治疗,效果良好。近日,因右脚趾出现较为严重的水疱3月余而来院就诊(如图A)。据该男子主诉,他近段时间脚趾部位未曾有接触过任何鱼类、海水或去过水族馆。体格检查可见,其肌肉发达的右腿部位有颜色不断加深的粉红色疼痛性结节,同时还渗出黄色的渗液(如图B)。30°C下作组织培养菌落光滑,光照产色(如图C),和生化检测结果均支持诊断为分枝杆菌感染。作肺结核的

男性,25岁,以往有患过克罗恩病病史,以英夫利昔单抗治疗,效果良好。


近日,因右脚趾出现较为严重的水疱3月余而来院就诊(如图A)。据该男子主诉,他近段时间脚趾部位未曾有接触过任何鱼类、海水或去过水族馆。



体格检查可见,其肌肉发达的右腿部位有颜色不断加深的粉红色疼痛性结节,同时还渗出黄色的渗液(如图B)。

30°C下作组织培养菌落光滑,光照产色(如图C),和生化检测结果均支持诊断为分枝杆菌感染。作肺结核的干扰素-γ释放试验,结果阳性。

磁共振成像检查结果显示,脚部的深部组织尚未见异常。

主治医生针对该男子的情况,停止使用英夫利昔单抗药物,改为采用强力霉素和克拉霉素进行治疗12个月,症状有所改善。同时,加用利福平药物辅助治疗加强治疗效果,持续到该男子的症状得到解决。

其实,非典型分枝杆菌的孢子丝菌病样皮肤淋巴性传播曾经在那些使用肿瘤坏死因子抑制剂(TNF-α)的案例中有在提到过,因为TNF-α具有维持肉芽肿及限制巨噬细胞内分枝杆菌生长的重要作用。

目前,肿瘤坏死因子抑制剂的应用是广泛的。在本案例中,这个患者所表现出的孢子丝菌病样皮肤症状,更加地表明了结核分枝杆菌感染的可能性。

原始出处:

Jessica Kim So, Taraneh Paravar.Sporotrichoid Mycobacterial Infection.N Engl J Med.October 29, 2015

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1754533, encodeId=ae0c1e5453315, content=<a href='/topic/show?id=9a804539828' target=_blank style='color:#2F92EE;'>#孢子丝菌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45398, encryptionId=9a804539828, topicName=孢子丝菌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f04936720113, createdName=yangpeizhi, createdTime=Wed Mar 09 22:29:00 CST 2016, time=2016-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42228, encodeId=082842228d3, content=恐怖, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:11:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42229, encodeId=b953422298d, content=拼了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:11:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42230, encodeId=0f9b42230ba, content=课程要积分很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:11:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1754533, encodeId=ae0c1e5453315, content=<a href='/topic/show?id=9a804539828' target=_blank style='color:#2F92EE;'>#孢子丝菌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45398, encryptionId=9a804539828, topicName=孢子丝菌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f04936720113, createdName=yangpeizhi, createdTime=Wed Mar 09 22:29:00 CST 2016, time=2016-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42228, encodeId=082842228d3, content=恐怖, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:11:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42229, encodeId=b953422298d, content=拼了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:11:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42230, encodeId=0f9b42230ba, content=课程要积分很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:11:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2015-11-02 nizongzan

    恐怖

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1754533, encodeId=ae0c1e5453315, content=<a href='/topic/show?id=9a804539828' target=_blank style='color:#2F92EE;'>#孢子丝菌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45398, encryptionId=9a804539828, topicName=孢子丝菌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f04936720113, createdName=yangpeizhi, createdTime=Wed Mar 09 22:29:00 CST 2016, time=2016-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42228, encodeId=082842228d3, content=恐怖, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:11:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42229, encodeId=b953422298d, content=拼了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:11:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42230, encodeId=0f9b42230ba, content=课程要积分很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:11:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2015-11-02 nizongzan

    拼了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1754533, encodeId=ae0c1e5453315, content=<a href='/topic/show?id=9a804539828' target=_blank style='color:#2F92EE;'>#孢子丝菌病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45398, encryptionId=9a804539828, topicName=孢子丝菌病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f04936720113, createdName=yangpeizhi, createdTime=Wed Mar 09 22:29:00 CST 2016, time=2016-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42228, encodeId=082842228d3, content=恐怖, beContent=null, objectType=article, channel=null, level=null, likeNumber=125, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:11:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42229, encodeId=b953422298d, content=拼了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:11:00 CST 2015, time=2015-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42230, encodeId=0f9b42230ba, content=课程要积分很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ded71629504, createdName=nizongzan, createdTime=Mon Nov 02 13:11:00 CST 2015, time=2015-11-02, status=1, ipAttribution=)]
    2015-11-02 nizongzan

    课程要积分很多

    0

相关资讯

ACG 2015:粪便移植究竟有没有效?

艰难梭菌目前是美国影响疾病健康的主要菌种,大约有20%的人群在治疗原始感染之后会发生艰难梭菌感染,40%-60%感染过该菌的人群未来会出现反复感染。已有研究表明,粪便微生物群移植可以减少患者艰难梭菌反复感染。不过也有研究表明,粪便移植和安慰剂组没有差异。近期的一项随机对照试验却显示出了混合的结果。该研究共纳入了46名感染艰难梭菌次数≥3次,且万古霉素治疗无效。22名患者分到了粪便移植组,经过3天的

李炳辉——糖尿病足处理的临床路径

在2015年国际腔内血管学大会,来自华中科技大学同济医学院附属梨园医院的李炳辉主任为我们介绍了糖尿病足处理的临床路径。 糖尿病足坏疽是糖尿病最常见且较严重的并发症之一,有截肢及威胁患者生命的可能。作为临床医生,需明确认识危险因素,及时有效的对患者进行治疗;需多学科团队合作,降低下肢截肢的风险;若发生截肢,应明确截肢平面,尽量保障肢体功能。 初步病情评估:

NEJM:对乙酰氨基酚在疑似感染的危重患者的应用效果

NEJM:对乙酰氨基酚在疑似感染的危重患者的应用效果对乙酰氨基酚是治疗ICU患者发烧以预防感染的一种常用的药物,但是其确切效果却尚未清楚。本研究随机分配了700例ICU发烧患者(体温≥38°),感染或疑似感染患者接受1g的对乙酰氨基酚(345名)或安慰剂(344名)静脉注射治疗,每6小时注射一次,直至ICU转出,体温降至正常,停止抗菌治疗或患者死亡。本研究评估的主要指标为患者存活的天数以及无需IC

CMAJ:膝关节和髋关节术后应用抗生素真的有效吗?

CMAJ:膝关节和髋关节术后应用抗生素真的有效吗?尽管目前为止支持关节术后应用抗生素可减少感染的证据很少,但是关节术后通常会常规应用处方抗生素以预防感染的发生,近日一篇关于此的评论性文章发表于CMAJ。膝关节和髋关节术后的感染是很严重的,需要再次进行手术,也可引起潜在的并发症。手术前后常规应用抗生素以减小感染发生的风险,尽管很少有证据表明术后应用抗生素可减少感染的发生。作者指出,研究表明抗生素骨水

NEJM:感染性脑静脉血栓形成案例报道

女性,71岁,因右耳后出现疼痛,疼痛范围辐射到右眼球后方5天余入院就诊。据该女士主诉,其还伴随有恶臭鼻涕、全身发冷、复视和右眼肿胀等症状。体格检查可见其右上睑下垂、右眼球结膜水肿、视力为20/32、眼球运动功能受限,并伴有三叉神经感觉减退症状(如图A和图B所示)。为了明确该女士的诊断,对其做进一步增强磁共振成像检查,结果显示在其右眼上静脉(图C)、海绵窦(图D)、岩下窦(图E)以及颈内静脉(图F)